This report describes the effects of treatment with lithium (Li), rubidium (Rb) and sodium (Na; 1 mEq/kg/day) for 7 days on norepinephrine (NE) turnover in mouse heart. The effects of several drugs which modify the uptake and storage of NE were also studied in similarly pretreated mice. A method based on the combustion of tissue tritium to tritiated water was used to assay tritiated l-norepinephrine (l-NE-3H) concentrations in individual hearts. The rate of decline of tissue tritium concentrations in groups of pretreated mice maintained at ambient temperature (23–24 °C) or in the cold (4-5 °C) was determined. The results indicate that, compared to Na, Li and Rb did not modify the tritium turnover rate in mouse heart. Pretreatment with Li or Rb did not modify the uptake of tritiated NE in the heart. The effects of desipramine, cocaine, bretylium and chlorpromazine on NE uptake were not altered by the alkali ions. Further, pretreatment did not modify NE release by tyramine, metaraminol and guanethidine. These studies suggest that Li and Rb do not modify NE uptake, release and storage in mouse heart.

Keywords:
Lithium, Rubidium, Tyramine, Reserpine, Metaraminol, Guanethidine, Desipramine, Chlorpromazine, Cocaine, Bretylium
This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.